VERITAS PHARMA’S ANNOUNCES STOCK OPTION GRANT

November 10th , 2017, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), an emerging discovery and IP development company, announces that it has issued 1,300,000 options to consultants of the Company under the stock option plan at an...

The Veritas Newsletter

Enter your email to receive news alerts and updates from Veritas Pharma.

You have Successfully Subscribed!